NEW YORK, NY / ACCESSWIRE / May 27, 2022 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ:ENOB). Investors who purchased Enochian securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/enob.
The investigation concerns whether Enochian and certain of its officers and/or directors have violated federal securities laws.
On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the co-founder of Enochian, had been arrested and charged in a murder-for-hire conspiracy. On this news, Enochian’s stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
If you are aware of any facts relating to this investigation or purchasedEnochian shares, you can assist this investigation by visiting the firm’s site: www.bgandg.com/enob. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com:
https://www.accesswire.com/703022/Bronstein-Gewirtz-Grossman-LLC-Notifies-Shareholders-of-Enochian-Biosciences-Inc-ENOB-Investigation